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ABSTRACT Eya proteins are transcription factors
that play pivotal roles in organ formation during devel-
opment by mediating interactions between Sine Oculis
(SO) and Dachshund (DAC). Remarkably, the tran-
scriptional activity of Eya proteins is regulated by a
dephosphorylating activity within its Eya domain (ED).
However, the molecular basis for the link between
catalytic and transcriptional activities remains unclear.
Here we report the first description of the crystal
structure of the ED of human Eya2 (ED-Eya2), deter-
mined at 2.4-Å resolution. In stark contrast to other
members of the haloacid dehalogenase (HAD) family
to which ED-Eya2 belongs, the helix-bundle motif
(HBM) is elongated along the back of the catalytic site.
This not only results in a structure that accommodates
large protein substrates but also positions the catalytic
and the SO-interacting sites on opposite faces, which
suggests that SO binding is not directly affected by
catalytic function. Based on the observation that the
DAC-binding site is located between the catalytic core
and SO binding sites within ED-Eya2, we propose that
catalytic activity can be translated to SO binding
through DAC, which acts as a transcriptional switch. We
also captured at two stages of reaction cycles-acyl-
phosphate intermediate and transition state of hydroly-
sis step, which provided a detailed view of reaction
mechanism. The ED-Eya2 structure defined here serves
as a model for other members of the Eya family and
provides a framework for understanding the role of
Eya phosphatase mutations in disease.—Jung, S.–K.,
Jeong, D. G., Chung, S. J., Kim, J. H., Park, B. C.,
Tonks, N. K., Ryu, S. E., Kim, S. J.. Crystal structure of
ED-Eya2: insight into dual roles as a protein tyrosine
phosphatase and a transcription factor. FASEB J. 24,
560–569 (2010). www.fasebj.org
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The coordinated actions of protein tyrosine phos-
phatases (PTPs) and protein tyrosine kinases control
essential cellular signaling involved in regulating cell
growth, differentiation, transcription, and metabolism
(1). The human PTP family, which consists of 107
members, comprises three classes of Cys-based PTPs
and one class of Asp-based PTPs, defined by their
substrate specificity and structural characteristics (2).
Although Cys-based PTPs have been well characterized
biologically and structurally, Asp-based Eya phospha-
tases have only recently been characterized as PTPs. Eya
phosphatases do not resemble Cys-based PTPs, which
use cysteine as a nucleophile in a catalytic reaction that
involves a thiol-phosphate intermediate. Instead, Eya
phosphatases use aspartic acid as a nucleophile in a
metal-dependent reaction.
Four isoforms of Asp-based Eya phosphatases are
conserved among different species of mammals and
other organisms, including plants. Eya phosphatases
have a C-terminal Eya domain (ED) of 275 aa in
common and have some homology to the haloacid
dehydrogenases (HADs) (3, 4). Most Eya phosphatases
have a transcription-activating domain at the N termi-
nus that comprises 200–250 aa. Eya genes were iden-
tified initially for the critical role they played in diverse
developmental processes in metazoans. For example,
hypomorphic eya alleles in Drosophila result in loss or
severe defects of the eye. Complete knockout of eya
function is embryonically lethal, the result of defects in
head morphology, gonad formation, and body wall
musculature (5). In the Drosophila eye, the ED of Eya
phosphatases has been shown to bind two retinal
determination proteins, Sine Oculis (SO) and Dachs-
hund (DAC), which mediate transcriptional activation
of downstream genes (6, 7). The recent identification
of the ED as a PTP ascribed a second essential function
to Eya (8–11). That Eya’s transcriptional role might
somehow depend on its PTP activity has been suggested
by recent studies, which have shown that disruption of
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PTP activity correlates strongly with its transcriptional
activity and related role in organ formation (8–10).
Quite recently, Eya phosphatases are known to be
involved in DNA damage repair by regulating the level
of phosphorylation at the C-terminal tyrosine residue of
H2A.X (12, 13).
Although the function and regulation of Eya phos-
phatases have been studied extensively, their molecular
architecture is largely unknown. Eya phosphatases be-
long to the HAD structural family, but sequence ho-
mology between the ED of Eya and HAD members is
very low and limited to 3 conserved catalytic motifs.
Further, the130 residues of the inserted helix-bundle
motif (HBM) in the ED are not similar to any HAD
members (14). An understanding of Eya phosphatase
catalysis mechanisms, substrate specificity, and interac-
tions with DAC and SO requires structural investiga-
tion. We showed previously that ED-Eya had an unusu-
ally negative charged surface that helps accommodate
histone H2A.X as a substrate (13). Here we report the
crystal structure of human ED-Eya2 at 2.4-Å resolution
in detail. Its helices are unexpectedly elongated along
the back of the active site, in contrast to the helices of
known HADs, which are tightly packed and capped
over the active site. This unusual association provides
insight into how its two functions—phosphatase and
transcription factor—can be regulated. Together with
a native structure, we report here two complexed
structures mimicking phosphoenzyme intermediate and
transition state analog bound. These provide new in-
sight into the reaction mechanism for substrate binding
and for phosphotransfer reaction. Our analysis of ED-
Eya2 establishes a structural basis for substrate specific-
ity and a framework for understanding mutations that
lead to defective Eya phosphatases associated with
human branchio-oto-renal (BOR) syndrome, deafness,
and optical defects (ODs) (15, 16).
MATERIALS AND METHODS
Expression and purification
A full-length clone of human Eya2 (gene accession no.
BC008803; OpenBiosystems, Huntsville, AL, USA) was sub-
cloned into pET28a. ED-Eya2 (residues 268–538) was ex-
pressed in the BL21 (DE3) strain of Escherichia coli. Cells were
grown at 295 K after induction with 0.1 mM IPTG for 20 h.
Cells were harvested and suspended in buffer containing 50
mM Tris-HCl (pH 7.5), 500 mM NaCl, 1 mM PMSF, 0.05%
(v/v) 2-mercaptoethanol, and 5% (v/v) glycerol. After lysing
cells by sonication, His-tagged ED-Eya2 was purified using
nickel-affinity chromatography, and the histidine-tag was re-
moved by thrombin protease digestion. ED-Eya2 was purified
further by DEAE-Sepharose FF ion exchange chromatogra-
phy and gel filtration chromatography, then equilibrated with
buffer containing 20 mM HEPES–NaOH (pH 7.0), 0.2 M
NaCl, 5 mM MgCl2, 2 mM DTT, and 5% glycerol. The
catalytic activity of ED-Eya2 was determined using a spec-
trofluorometric assay (see Supplemental Data). To prevent
protein oxidation, 20 mM DTT was added, and the protein
was concentrated to 18 mg/ml for crystallization.
Crystallization and data collection
Crystallization was performed at 291 K using the hanging-
drop vapor diffusion method. Initial trials were performed
using commercial screening kits (Hampton Research, Aliso
Viejo, CA, USA). Optimal crystals were formed by mixing 1.8
l of protein solution with an equal volume of reservoir
solution containing 0.1 M bis-Tris (pH 6.0) and 2.4 M NaCl
and growing for 3 d. X-ray diffraction data were collected on
the Pohang Accelerator Laboratory (Pohang, Korea) beam-
line 4A equipped with an ADSC quantum detector (Area
Detector Systems Corp., Poway, CA, USA). For cryoprotec-
tion, the crystals were soaked in a reservoir solution contain-
ing 20% (v/v) glycerol. The crystal diffracted to 2.4 Å
resolution and belonged to the space group I4, with unit cell
parameters of a  b  183.61 Å, c  120.15 Å,      
90°. The collected diffraction data were processed and scaled
with Mosflm (17) and Scala (18). ED-Eya2 complexed with
AlF3 (or with BeF3) was obtained by reacting purified ED-
Eya2 with 0.1 mM of AlCl3 (or 0.1 mM BeCl3) and 10 mM of
NaF for 30 min at 277 K. The complexed crystals were grown
under the same conditions as native crystals. X-ray diffraction
data were collected at SPring8 (Hyogo, Japan) beamline
BL38B1. The collected diffraction data were processed and
scaled using Denzo and Scalepack software (19). Data collec-
tion statistics are shown in Table 1.
Structure solution and refinement
The structure of ED-Eya2 was determined by the multiple
isomorphous replacement method using two heavy-atom de-
rivatives. The first derivative was obtained by soaking native
crystals for 1 h in the mother liquor containing 1 mM
KAu(CN)2. The second heavy-atom derivative was obtained by
soaking for 2 h in mother liquor containing 1 mM Sm(OAc)3.
The locations of heavy atoms, heavy-atom parameter refine-
ment, and phase calculation were carried out using the
program SOLVE (20). Subsequent solvent flattening and
noncrystallographic symmetry (NCS) averaging were performed
using the program RESOLVE (20). The resulting electron-
density map enabled the building of a majority of the residues.
The ED-Eya2 crystal contained four protomers. The initial and
iterative model building were performed using the program O
(21). However, the crystals tended to show merohedral twin-
ning. To detect merohedral twinning and estimate the
twinned fraction, a merohedral crystal twinning server (22)
was used. The value of the twinned fraction was 0.35, indicat-
ing that the ED-Eya2 crystal was partially twinned, with a twin
operator of h, -k, -l. The model was refined using the program
CNS, taking partial twinning into account (23). NCS re-
straints were applied during refinement and released in the
final stage. The final Rcryst and Rfree were 16.8 and 21.4%,
respectively (Table 1). A Ramachandran plot drawn using
Procheck (24) showed that 89.5 and 10.2% of all residues lay
in the most favored and additionally favored regions, respec-
tively. No residues were found in the disallowed regions. The
final model includes the residues 268–355 and 372–538 for
protomer A (a model discussed in the text), the residues
268–356 and 375–538 for protomer B, the residues 268–355
and 372–538 for protomer C, the residues 268–356 and
372–538 for protomer D, 4 magnesium ions, and 115 water
molecules. For protomers A and C, the 3 residues preceding
the N terminus of the thrombin cleavage site were included in
the model. The native ED-Eya2 model was taken as a starting
point for refinement of complexed ED-Eya2, and the same
refinement protocols of native ED-Eya2 were applied. Al-
though electron densities for AlF3 or BeF3 were evident, these
were built into the structure at the final stage of the refine-
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ment. Figures were drawn using the programs Ribbons (25),




We determined the structure of ED-Eya2 using the
multiple isomorphous replacement method at 2.4-Å
resolution. Because other Eya members have 60%
sequence identity with Eya2, they are likely to be folded
similarly. The 4 protomers (A–D) in the asymmetric
unit had similar conformations and formed 2 potential
dimers (A:B and C:D) related by 2-fold NCS. However,
a gel-filtration experiment indicated that ED-Eya2 ex-
ists as a protomer in solution (data not shown), so these
dimeric contacts are not likely to be significant.
The crystal structure (Fig. 1A) shows a novel arrange-
ment comprising 2 domains: a HAD-like catalytic do-
main consisting of N-terminal (267–282) and C-termi-
nal residues (424–538), and an HBM comprising 7
helices (residues 283–423) that lies between the N- and
C-terminal regions. Based on a structural homology
search using the DALI server (27), the HAD-like do-
main was found to possess a typical / hydrolase fold
and belonged to the HAD family. Several HAD mem-
bers, including enolase-phosphatase e1 (MASA; PDB
code 1yns, Z score12.3) (28), sugar phosphate phos-
phatase bt4131 (PDB code 1ymq, Z score11.4) (29),
L-2 haloacid dehalogenase (PDB code 1qq5, Z score
10.6) (30), and phosphoserine phosphatase (PSP; PDB
code 1f5s, Z score9.7) (31) were identified. An align-
ment of ED-Eya2 with MASA superposed 104 of 140 C
atoms with a root mean square (RMS) deviation of 1.5
Å (Fig. 1B). The HAD-like domain contains a parallel,
5-stranded  sheet (1–5) flanked by 4 helices (8,
10–12). Helix 9 is inserted between strands 2 and
3 and is positioned in the direction of the  sheet. A
structural homology search using DALI (27) showed
that, in contrast to the HAD-like domain, the HBM of
Eya2 has no structural homologue with a Z score  4.0.
The HBM is composed solely of 7 helices that are
elongated across the back side of the catalytic domain
and wrap around helix 9 of the catalytic domain.
Active site
The active site shared by members of the HAD family is
defined by 3 conserved sequence motifs (Figs. 1B and 2A)
and a bound magnesium ion. The conserved residues,
which are critical in catalysis, are generally well aligned,
which suggests that Eya shares a common catalytic
mechanism with other HADs. Based on the structural
alignment with MASA, Asp274 is well superposed with a
nucleophile in MASA. Asp274 is positioned optimally
and anchored by a magnesium ion. Asp276 is predicted
to act as a general acid/base by stabilizing the leaving
group during the first step and is then involved in
activating water-mediated hydrolysis of the phosphoen-
zyme complex. Asp276 is directed toward the active site
and occupies a position similar to that of general
acid/base residue in MASA. Thr278 is positioned in the
-turn structure and contacts Asp274 and Asp502. This
TABLE 1. Data collection, phasing, and refinement statistics
Statistic Native Golda Samariumb BeF3 AlF3
Resolution limit (Å) 2.4 2.5 2.7 2.5 2.5
Observations 360,049 336,289 256,298 504,660 484,549
Unique reflections 77,791 68,979 50,520 68,947 68,352
Completeness (%)c 99.8 (99.9) 99.9 (99.9) 94.1 (95.2) 99.7 (98.4) 99.8 (99.9)
Multiplicity 4.6 (4.7) 4.9 (5.0) 5.1 (5.1) 7.3 (6.5) 7.1 (6.4)
I/I 6.9 (2.5) 7.1 (3.8) 7.0 (2.3) 26.9 (2.4) 25.7 (2.4)
Rmerge (%)
d 7.9 (29.3) 7.0 (19.8) 7.7 (33.0) 7.4 (44.4) 8.4 (55.1)
Heavy-atom sites 6 3
Refinement
Resolution range (Å) 50–2.4 50–2.5 50–2.5
Reflectionse 76,896 (3694) 64,507 (3281) 62,438 (3066)
Atoms (protein/nonprotein) 8268/119 8292/159 8274/163
Rcryst/Rfree (%) 16.8/21.4 22.4/25.4 20.0/24.0
RMS deviation
Bond distances (Å) 0.008 0.007 0.008
Bond angles (deg) 1.27 1.25 1.30
Impropers (deg) 0.74 0.73 0.70
Dihedral angles (deg) 21.3 21.4 21.0
Thermal factor (Å2)
Main-chain atoms 41.3 47.2 44.8
Side-chain atoms 42.1 48.6 46.3
Nonprotein atoms 31.0 36.8 32.7
a Potassium gold cyanide. b Samarium acetate. c Values in parentheses are for the highest-resolution shell. dRmerge  iIi 	 
I/

I, where I is the intensity for the ith measurement of an equivalent reflection with the indices h, k, l. eValues in parentheses are for the
Rfree data set.
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interaction may help two aspartates coordinate a mag-
nesium ion and may be crucial for enzymatic function.
Lys480 is predicted to play a role in substrate binding.
Although the C position of Lys480 in Eya2 is different
from that of the equivalent residue in MASA (28), the
side chain occupies a similar position. In motif III, the
side chain of another glutamate (Glu506), strictly con-
served in Eya homologs, is positioned at the rim of the
active site and contributes a negative charge to the
active-site cradle. These structural observations are con-
sistent with the observation that the corresponding
mutations result in a marked decrease in in vitro
phosphatase activity (8–10, 32).
Structure of BeF3-Eya2 complex mimicking a
phosphoenzyme intermediate
Complexation with BeF3 did not lead to drastic alter-
ation in overall structure, but some significant differ-
ences were found (Supplemental Fig. S1A, B). The
superposition of BeF3-complexed ED-Eya2 structure
with that of the native structure shows that the 4-5
loop, 2-9 loop, and 3-10 loop move toward BeF3
molecule. These loops are spatially concentrated on
one region that includes catalytic motif II (Supplemen-
tal Fig. S1B), which suggests that this region has an
intrinsic mobility that allows lateral movement on sub-
strate binding.
The beryllium atom of BeF3 is covalently attached to
OD1 atom of Asp274 with nearly ideal tetrahedral
geometry, mimicking a stable phosphor-aspartyl en-
zyme intermediate (Fig. 2B). The 3 fluorine ions of
BeF3 engage in extensive interactions with side-chain
atoms of Thr447, Thr448, Lys480, a main-chain atom of
Asp276, and a magnesium ion, which might stabilize
the complex in the intermediate state. Another notable
change is that the side chain of Asp276 moves 2.4 Å
toward the BeF3 molecule, confirming the role of
Asp276 as a general acid/base in the Eya phosphatase.
The shift of Asp276 is coupled to creation of an
ordered water molecule between Asp276 and Glu277
(OD1 in Asp276–OH2 in Wat1, 2.7 Å; OE1 in Glu277–
OH2 in Wat1, 2.6 Å; Fig. 2B). This geometry would be
expected to facilitate formation and cleavage of the P-O
bond between Asp274 and the phosphate group by
activating a water molecule (Fig. 2C). In protein ty-
rosine phosphatase 1B (PTP1B), a prototype of Cys-
based PTPs, a general acid/base (Asp181) is not suffi-
cient for complete catalysis; a glutamine residue (Gln262)
near Asp181 is thought to help facilitate the second
step of the catalytic reaction by activating a water
molecule. A mutation at this glutamine resulted in a
100-fold decrease in catalytic activity, suggesting that it
is critical for hydrolysis of the phosphoenzyme complex
(33). Glu277 in Eya2 might also indirectly assist a water
molecule for attack during the hydrolysis of the phos-
phoenzyme complex.
Structure of AlF3-Eya2 complex mimicking a
transition state of phosphoenzyme
AlF3 occupies a nearly identical position to that of BeF3
in ED-Eya2-BeF3 complex, but AlF3 adopts a planar
instead of tetrahedral geometry (Fig. 2D). The alumi-
num atom is 2.0 Å from the OD1 atom of Asp274, and
3 fluorine ions have similar interactions with those of
the BeF3-complexed structure. One notable exception
is that a water molecule optimal for nucleophilic attack
is not seen in AlF3-complexed ED-Eya2. In the case of
both phosphoserine phosphatase (34) and Fcp1 com-
plexed with aluminum fluoride (35), a water molecule
sits above the aluminum fluoride plane, maintaining a
Figure 1. ED-Eya2 structure. A) Ribbon diagram of ED-Eya2. Catalytic domain (orange) and HBM (cyan). The catalytically active
Asp274 and magnesium ion are drawn as ball-and-stick models. Secondary structural elements defined by the program Procheck
(21) are labeled on the drawing. Secondary structural elements (and boundaries) are 1 (270–274), 2 (441–447), 3
(472–474), 4 (496–501), 5 (517–519), 1 (283–286), 2 (289–294), 3 (298–319), 4 (322–325), 5 (376–394), 6
(398–401), 7 (406–420), 8 (424–437), 9 (451–460), 10 (480–491), 11 (504–512), and 12 (523–535). B) Structure-
based alignment of Eya2 with MASA. Superposition was performed using the O program (18) using the criteria of 
3.8 Å for
3 consecutive C atoms. In the resulting alignment, 104 C atoms were superposed, with an overall RMS deviation of 1.5 Å.
Superposed residues are shaded yellow. Eya2 secondary structural elements (blue) appear above the alignment; those of MASA
(red) are below the alignment. Catalytically important residues are indicated by inverted arrowheads. Residues corresponding
to consensus motifs of HAD family are enclosed in the box.
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good geometry for nucleophilic attack—an architec-
ture supportive of an associative reaction pathway. In
AlF3-complexed ED-Eya2, the nearest water molecule is
distant from the aluminum atom (3.6 Å) and does
not have inline geometry with respect to the Al-O bond
for nucleophilic attack (water, aluminum, and OD1 of
Asp274 subtend a 138° angle). Further, this water is not
coordinated with a general base, Asp276. This finding
suggests little participation of solvent molecule as a
nucleophile during C-O bond breakage. Thus, we pro-
pose that ED-Eya2 catalyzes hydrolysis via a dissociative
mechanism, instead of addition-elimination pathway.
However, we do not preclude the possibility of associa-
tive reaction pathway at this medium resolution.
Structure of HBM in ED-Eya2 is distinct
Whereas the HAD catalytic domains are structurally
well conserved, the intervening HBMs are structurally
divergent, perhaps conferring specificity and variety to
members of the HAD family (14). Despite their struc-
tural diversity, the HBMs of different HAD members
share certain features. HBMs are usually composed of 4
helices and are located at the top of the active site, thus
constituting a potential pocket for specific substrates.
Although the orientation and location of HBMs differ,
HBMs cover the active site and thus restrict substrate
access (Fig. 3). Access to the active-site pocket varies
according to the individual enzyme and its specific
substrate. However, the HBM in Eya2 is completely
distinct in several aspects. First, it consists of 140 aa
(other HADs have 55–105) (14) and has 7 helices in an
elongated arrangement (other HADs have 4 tightly
packed helices). A homology search using the DALI
server (27) also confirmed that the folding of HBM in
ED-Eya2 is unique (similarity 
4 in terms of Z score).
However, the most prominent difference is the mode of
association with the catalytic domain. In ED-Eya2, the 7
Figure 2. Catalytic mechanism of ED-Eya2.
A) ED-Eya2 active-site residues are presented as
ball-and-stick models. The electron-density 2Fo-Fc
map contoured at the 1.5- level is also presented,
superimposed on the refined model. Ionic and
hydrogen bond interactions (
3.2 Å) are
shown as dashed lines. B) Active site of native
ED-Eya2 (ivory) is superimposed on that of
ED-Eya2 complexed with BeF3 (black). Atoms
of carbon, nitrogen, oxygen, magnesium, be-
ryllium, and fluorine are pale pink, blue, red, green, cyan, and violet, respectively. Hydrogen bonding and ionic contacts
around the active site of complexed ED-Eya2 are represented by dashed lines. C) A hypothetical 2-step reaction mechanism
for ED-Eya2. A water molecule between Asp276 and Glu277 facilitates the formation and the breakdown of the
phosphoenzyme complex by assisting the general acid/base, Asp276. D) Active site of ED-Eya2 complexed with AlF3.
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helices traverse the outside of the catalytic domain and
result in a completely open active site (Fig. 3). The
open active site might help protein substrates, includ-
ing H2A.X, access the site and facilitate catalysis (13).
Role of mutations in Eya-related disorders
The high level of similarity among the primary se-
quences of Eya phosphatases suggests that the struc-
tures of Eya family members may also be similar. Using
the ED-Eya2 structure as a platform, we examined
disease-associated Eya mutations to investigate possible
relationships between mutation positions and patho-
genic effects. To date, 100 Eya mutations have been
reported (3, 4). Most are nonsense, insertion/deletion,
or splice-site mutations. Fifteen missense mutations
that often lead to BOR syndrome, deafness, OD, and
loss of function in Drosophila alleles (36–39) can be
used to identify residues that are important for protein
function or stability (Table 2 and Fig. 4A). To gain
further insight into the roles of each mutation, we also
calculated fractional solvent accessibility (FSA) for the
side chain of each residue and the change in protein
stability induced by mutations (40). These are excellent
tools for investigating potential protein–protein inter-
actions and protein structure-destabilizing mutations.
Overall, mutations of residues that have low FSA values
are predicted to have a substantial negative effect on
protein stability.
The studied mutations can be grouped into catalytic
active site, protein core, and protein surface mutations
according to the positions of the native residues. At 6
sites within the hydrophobic core of the protein, mu-
tation results in the replacement of the original residue
with a bulkier or altered charged residue: V270E,
Q330X, T421I, N433P, L451R, and L529P (where X
Figure 3. Structural comparison between Eya2 and other HAD proteins. Schematic diagrams showing the Eya2, haloacid
dehalogenase (PDB code 1QQ5), phosphoserine phosphatase (PDB code 1L7P), and enolate phosphatase E1 (PDB code
1YNS), drawn to a common orientation and scale. Catalytic domain and HBM are colored differently, and the position of the
active site magnesium ion is shown as a purple sphere to represent the location of the catalytic core.
TABLE 2. Mutations in the ED of Eya phosphatases
Corresponding residue
in Eya2 Mutation Protein studied
Related diseases or loss
of function Roles in Eya2 structurea
Predicted G
upon mutationb
Val270 V3E hEya1 BOR Str./0.03 10
Thr278 T3M hEya1/mEya3/Fly Eya loss of function Str., Cat./0.0 6.20
Met307 R3X5 hEya1 BOR 	/0.49 	
Glu309 E3K hEya1/mEya3/Fly OD 	/0.37 2.00
Gln330 Q3X hEya1 BOR Str./0.04 	
Gly372 G3S hEya1/mEya3/Fly BOR/OD 	/0.96 3.64
Asp375 D3G hEya1 BOR/Deafness 	/0.75 3.94
Arg386 R3Q hEya1 BOR/Deafness 	/0.26 0.89
Gly400 G3R hEya1 BOR 	/0.47 	1.87
Thr421 T3I hEya1/mEya3/Fly Eya loss of function Str./0.02 1.78
Asn433 S/L3P hEya1/mEya3/Fly BOR Str./0.01 10
Leu451 L3R hEya1/mEya3/Fly BOR Str./0.02 10
Arg493 R/K3G hEya1/mEya3/Fly OD 	/0.93 1.15
Gly501 G3E hEya1/mEya3/Fly Eya loss of function Str., Cat./0.0 10
Leu529 L3P hEya1/Fly BOR Str./0.02 10
Str., structural role; Cat., catalytic role; X, any amino acid. aValues on right are fractional solvent accessibility (FSA) for each residue,
calculated using the program QUANTA as the ratio of the side-chain FSA for residue X to the FSA obtained after reducing the structure to a
Gly-X-Gly tripeptide. bValues of mutation-induced stability change (G) relative to wild type.
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indicates any residue); most of these substitutions are
predicted to destabilize the protein. One exception is
the T421I mutation, which probably does not have a
major effect on stability because it does not substan-
tially increase size or alter the charge. Two missense
mutations, T278M and G501E, with FSA values ap-
proaching zero, occur at residues that have been impli-
cated in catalytic activity. As noted earlier, the side
chain of Thr278 forms hydrogen bonds with the crucial
Asp274 and Asp502 residues. Gly501 is a strictly con-
served residue in motif III. Mutation of these two
residues might affect core structure as well as catalytic
function. The remaining missense mutations (7 of 15)
have FSA values larger than 0.25 and correspond to
solvent-exposed residues. The positions of these resi-
dues suggest that they may be protein partner binding
sites and may thus have the potential to influence
transactivation function. Six of seven solvent-exposed
mutations are found on the same face of HBM at a
distance from the catalytic side. Two pairs of solvent-
exposed missense mutations, G372S/D375G and M307X/
E309K, are clustered on the same face of HBM opposite
the active site (Fig. 4B). Two other mutations, R386Q
and G400R, are located at isolated positions on the
same face. G372S is located in the 4-5 loop, whereas
D375G lies within helix 5; both are situated at the top
of the molecule (Fig. 4). Q330X, which is not fully
exposed to the solvent, is located within the same
region. The second cluster of mutation sites, M307X/
E309K, is located on helix 3. The only exception is a
mutation of arginine to glycine at residue 493, which is
located on the 10-4 loop on the catalytic face.
Potential binding site for SO is distant from the
catalytic site
Mutsuddi et al. (36) investigated the relationship be-
tween phosphatase and Eya-SO bipartite transcriptional
activities using point mutations that cause Eya-related
disorders (36). N433P and G501E mutations, located
near the catalytic core, and L451R mutation, located at
the interface between the catalytic domain and HBM,
eliminated phosphatase activity (Table 3). Considering
that those residues have very low FSA values and are
mutated to larger residues, the corresponding muta-
TABLE 3. Relationship between catalytic and transcriptional activities of mutant Eya
hEya2 mEya3 PTP activity Transcription activity Location in Eya2 structure2
N433 L405PBOR 	  CC
L451 L423RBOR 	 /	 I
R493 K465GOD   C
E309 E281KOD 	 	 H
G372 G344SBOROD  	 H
T278 T250MFLY   CC
T421 T393IFLY 	  I
G501 G473EFLY 	  CC
Activity data are from Mutsuddi et al. (36). CC, catalytic core; I, interface between domains; C,
catalytic domain; H, helix bundle motif.
Figure 4. Missense disease mutations. A) C positions of missense mutations found in Eya homologs are shown as green spheres on
a worm model of ED-Eya2. Magnesium ion is represented to indicate catalytic core. Point of view and color-coding scheme are the
same as in Fig. 1A. B) Missense mutations (blue) on the surface of the ED-Eya2 structure, mapped from the Eya homologs in blue.
Left: view facing the HBM. Diagram is rotated 90° along the y axis from the viewpoint of A. Right: opposite view from that of A.
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tions are likely to affect the native structure of the
catalytic domain. The R493G mutation, located within
the catalytic domain but distant from the catalytic core,
resulted in a reduction in phosphatase activity (Fig. 4A
and Table 3). One exception to the trend toward
reduced or absent phosphatase activity was the T278M
mutant, which displayed a level of activity similar to that
of wild-type Eya. Thr278 is located in the catalytic core,
and the hydroxyl group of Thr278 interacts with the
crucial Asp274 residue. Because Thr278 is one of three
consecutive threonine residues in the primary se-
quences (Figs. 1B and 2B), we reasoned that the other
two threonine residues might have functionally com-
pensated for the T3M mutation. Interestingly, the
corresponding T3A mutation in plant Eya results in
approximately a 50-fold reduction in catalytic activity
(41). Remarkably, most mutations in the catalytic do-
main retained significant transcriptional activity, imply-
ing that SO-directed transcription is independent of
catalytic activity.
In contrast to mutations in the catalytic domain,
HBM mutations produced conspicuous effects on tran-
scription. The mutations located at a distance from the
catalytic domain (E309K and G372S) resulted in a
complete loss of transcriptional activity. Notably, E309K
and G372S are exposed to the solvent and have been
implicated in BOR/OD diseases. Taken together, these
results lead us to propose that a surface of the HBM
opposite the catalytic core could be a major interaction
site that is required for SO-related transcription, inde-
pendent of the catalytic domain.
Implications for DAC repression-to-activation
switching
DAC/SO-mediated regulation is important for proper
transcription and subsequent mammalian organogene-
sis (9). DAC prevents SO-related transcription by re-
cruiting other corepressors, including NcoR, Sin, and
histone deacetylase. In addition, DAC is known to
interact strongly with SO and Eya through CREB bind-
ing protein (42). However, the phosphatase activity of
Eya enables Eya to convert the DAC-SO complex into a
transcription activator (9). Using Drosophila Eya phos-
phatase, Bui et al. (43) found that SO-binding spanned
residues 268–373 while that of DAC spanned residues
371–465 (corresponding to ED-Eya2 residue number-
ing). Mapping these regions onto the surface of the
ED-Eya2 structure reveals that the majority of SO-
binding sites lie opposite the catalytic domain, whereas
those of DAC lie between the catalytic domain and the
SO-binding site (Fig. 5). Although the catalytic site
overlaps slightly with the potential binding site for SO,
Tootle et al. (10) showed that mutations at the catalytic
site, including Asp274 in Eya2, did not affect the
interaction with SO. The observation that the SO-
binding site is distant from the catalytic site is consistent
with the above analysis and implies that SO binding to
Eya may not be related directly to phosphatase func-
tion. Thus, bioinformatics tools predict that the surface
opposite the catalytic face is as likely a protein interac-
tion surface as the catalytic site (See Supplemental Fig.
S2). In contrast, the observation that the DAC-binding
site in Eya is in the vicinity of the catalytic core suggests
that DAC binding may influence Eya catalytic function.
DISCUSSION
This study represents the first elucidation of structure
of ED-Eya2 in a new mechanistic class, aspartate-based
PTP. Further, we present the structure of human
ED-Eya2 with transition state and intermediate ana-
logues bound that provides insights into the mecha-
nisms by which Eya phosphatase functions. We demon-
strate that ED-Eya2 undergoes metal-assisted 2-step
reactions via phosphoaspartyl intermediate during ca-
talysis. Although additional biochemical evidence is
required, we provide the reaction mechanism through
which the transition state could proceed via dissocia-
tion. The structure reveals that ED-Eya2 has the com-
mon fold to that of HAD but also has several charac-
teristics that are divergent from those of HADs. The
crystal structure was found to have an unusual associa-
tion between the catalytic domain and the HBM.
Although the interactions of Eya with other proteins
Figure 5. Putative binding sites for SO and DAC. Putative SO- and DAC-binding sites are represented on a surface of the ED-Eya2
structure (left pair). SO-binding surfaces are green; DAC-binding surfaces are magenta. Remaining molecular surfaces are gray.
Right image of the pair was produced by rotating the left-hand viewpoint 180° along the y axis. Each ribbon diagram is
represented with the same viewpoint in the left pair. Bound magnesium ion is shown as a pink sphere to indicate the location
of the catalytic core.
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require further investigation, we could propose that
transcription factors interact at a surface that is distinct
from the catalytic site using structural and biochemical
information. Further, using bioinformatics tools, we
predicted a location for the potential interacting re-
gion, showing that a surface of the HBM opposite
catalytic face is a good candidate for protein-protein
interactions (Supplemental Fig. S2).
Two conceptually distinct mechanisms may govern
the relationship between the dual functions of Eya
phosphatase (4, 11). One is that phosphatase and
transcription factor activity are tightly linked, function-
ally and structurally. Alternatively, transcription may
operate in a phosphatase-independent manner. Al-
though evidence exists to support each mechanism, our
model allows us to speculate on the relationship be-
tween catalytic and transcriptional activities in a struc-
tural context. As noted earlier, the catalytic site and
SO-interacting site are spatially separated. Thus, Eya
can fulfill its transcriptional function with SO indepen-
dent of its phosphatase function. The fact that catalyt-
ically impaired Eya mutants and SO retained high basal
transcriptional activities supports this notion (10).
However, in other contexts, DAC plays a critical role in
transcription (9, 11). During transcriptional repres-
sion, DAC in a complex with its corepressor prevents
SO from binding to the transcription machinery. How-
ever, DAC binds to Eya, where it is held between the
catalytic domain and SO-binding site within Eya. Eya
then dephosphorylates an as-yet-unknown substrate
(possibly DAC or a corepressor complex), possibly triggering
a conformational transition of the flanking DAC with its
corepressor complex. This could concomitantly affect
the interface between DAC and SO, allowing the de-
tachment of the corepressor complex from DAC and
exposing a new Eya-DAC-SO binding interface that
could recruit related transcriptional coactivators. Caught in
the middle, DAC appears to act as a transcriptional
switch by translating Eya catalytic function into SO-
directed transcription. It is also worth noticing that the
loop movement in trapped intermediate structure is
propagated from active site to DAC binding site (Sup-
plemental Fig. S1B). Additional mutational analyses
based on the crystal structure presented here and
follow-up functional studies will help to clarify further
the relationship among Eya, DAC, and SO.
In summary, the catalytic part is spatially separated
from the transcriptional part, which enables ED-Eya to
act independently as a phosphatase and a transcription
factor. Our studies provide a structural basis for under-
standing the Eya-SO-DAC network in terms of phospha-
tase function and disease-associated mutations and, by
extension, should have implications for mammalian
organogenesis.
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